Lanean...
Assessing Efficacy in Early-phase Cancer Prevention Clinical Trials: The Case of Ki-67 in the Lung
This perspective on Kim et al. (beginning on p. XX in this issue of the journal) examines the value of the Ki-67 proliferation index as a surrogate endpoint in early-phase clinical lung-cancer prevention trials. The clinical trial of Kim et al. demonstrates an effect of the cyclooxygenase-2–selectiv...
Gorde:
| Egile nagusia: | |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2010
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2818869/ https://ncbi.nlm.nih.gov/pubmed/20103726 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-09-0268 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|